Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 8 Medulloblastoma 6 Recurrence 4 Skin Neoplasms 3 Basal Cell Nevus Syndrome 3 Thrombocythemia, Essential 2 Prostatic Neoplasms 2 Primary Myelofibrosis 2 Polycythemia Vera 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioma 2 Glioblastoma 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Astrocytoma 2 Thrombocytosis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Diseases 1

Interventions

Fulvestrant 19 Letrozole 8 Anastrozole 6 Capecitabine 5 palbociclib 4 olaparib 4 Paclitaxel 4 Injections 4 Goserelin 4 Docetaxel 4 pyrotinib 3 exemestane 3 trastuzumab deruxtecan 2 toripalimab 2 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 abemaciclib 2 Vinorelbine 2 Trastuzumab 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Aromatase Inhibitors 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2 vandetanib 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Breast Cancer × sonidegib × Clear all

NCT02027376 2023-04-03

EDALINE

Spanish Breast Cancer Research Group

Phase 1 Completed

12 enrolled 16 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡